BETA2,086.00

Beta Drugs Limited

· Unclassified
AnnualQuarterly₹ CrorePeersTHEJOMACPOWERSAKARSERVOTECHMcap ₹2,115 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations362.4384.8510.4
Other Income6.411.212.8
Total Income368.8396.0523.1
Expenses
+ Cost of Materials Consumed175.8173.8224.0
+ Changes in Inventories-4.4-2.61.7
+ Employee Benefit Expense34.068.075.1
+ Finance Costs7.015.317.9
+ Depreciation & Amortisation12.517.221.5
+ Other Expenses82.470.0106.5
Total Expenses307.3341.6446.7
EBITDA74.675.7103.0
EBIT62.158.581.5
Profit
PBT before Exceptional Items57.054.476.4
+ Exceptional Items-4.60.00.0
Pretax Income57.054.476.4
+ Current Tax15.013.719.5
+ Deferred Tax-0.4-0.8-1.0
Tax Expense14.612.918.5
Net Income42.441.558.0
+ Net Income — Continuing Ops41.5
+ Other Comprehensive Income0.2
Total Comprehensive Income41.7
Per Share
Basic EPS42.0240.9279.49
Diluted EPS42.0240.9279.49
Profit Build-up — Alternate / Pre-Ind-AS Tags
PBT before Exceptional & Extraordinary Items61.5
+ Adjustments to Profit / (Loss)19.5
Profit for the Period before Minority Interest42.4
Continuing & Discontinued Operations
Profit from Continuing Operations42.4
Other Comprehensive Income — detail
+ Other Comprehensive Income0.2
+ Items NOT to be Reclassified to P&L0.2
Per Share — as-filed variants
Basic EPS — Continuing Operations40.92
Diluted EPS — Continuing Operations40.92
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit191.0213.6284.7
Gross Margin %52.7155.5255.78
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)57.054.476.4
− Exceptional Items (reconciliation)-4.60.00.0
Net Income Adj (tax-effected)42.441.558.0
EPS Adj42.0240.9279.49
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.00
Filed Debt Equity0.01
Filed Dscr0.07
Filed Iscr0.09
Paid Up Equity Capital10.110.111.1
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.